Lipoprotein Particle Profiles by NMR Compared with Standard Lipids and Apolipoproteins in Predicting Cardiovascular Disease in Women

This Women’s Health Study analysis of 27,673 initially healthy women compared nuclear magnetic resonance lipoprotein particle profiling against standard lipid panels and apolipoprotein measurements for predicting cardiovascular events over a decade of follow-up.

LDL particle concentration by NMR was associated with CVD risk (HR 2.51 per quintile), but was not meaningfully superior to apoB (HR 2.57) or the total/HDL cholesterol ratio (HR 2.82). Adding NMR-measured LDL-P or apoB to models containing standard lipids produced essentially no net reclassification improvement (0% and 1.9%, respectively).

The finding offers an important counterpoint to the particle-number advocacy narrative. NMR particle counting is frequently marketed as a superior alternative to standard lipid testing — but this large, prospective study in healthy women found that it adds little predictive value over apoB, which can be measured more simply and cheaply by immunoassay. The practical implication is that apoB testing achieves the clinical goal of particle-number measurement without the complexity and cost of NMR profiling.

We rate the evidence strong. A large prospective study from a high-quality cohort demonstrating that NMR lipoprotein particle profiling does not meaningfully outperform apoB measurement for cardiovascular risk prediction — supporting apoB as the preferred clinical approach to particle-number based risk assessment.